Report Detail
Global Measles and Rubella Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4507816 |
- 04 February, 2023 |
- Global |
- 74 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Measles and Rubella Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Measles and Rubella Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Measles and Rubella Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Measles and Rubella Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Measles and Rubella Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Measles and Rubella Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Measles and Rubella Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Measles and Rubella Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Measles and Rubella Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monovalent Vaccines
Multivalent Vaccines
Market segment by Application
Hospital
Clinic
Others
Major players covered
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles and Rubella Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles and Rubella Vaccines, with price, sales, revenue and global market share of Measles and Rubella Vaccines from 2018 to 2023.
Chapter 3, the Measles and Rubella Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles and Rubella Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Measles and Rubella Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles and Rubella Vaccines.
Chapter 14 and 15, to describe Measles and Rubella Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Measles and Rubella Vaccines
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Measles and Rubella Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Monovalent Vaccines
- 1.3.3 Multivalent Vaccines
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Measles and Rubella Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Measles and Rubella Vaccines Market Size & Forecast
- 1.5.1 Global Measles and Rubella Vaccines Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Measles and Rubella Vaccines Sales Quantity (2018-2029)
- 1.5.3 Global Measles and Rubella Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Serum Institute of India Ltd.
- 2.1.1 Serum Institute of India Ltd. Details
- 2.1.2 Serum Institute of India Ltd. Major Business
- 2.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Product and Services
- 2.1.4 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Serum Institute of India Ltd. Recent Developments/Updates
- 2.2 Merck & Co. Inc.
- 2.2.1 Merck & Co. Inc. Details
- 2.2.2 Merck & Co. Inc. Major Business
- 2.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Product and Services
- 2.2.4 Merck & Co. Inc. Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Merck & Co. Inc. Recent Developments/Updates
- 2.3 GlaxoSmithKline Inc.
- 2.3.1 GlaxoSmithKline Inc. Details
- 2.3.2 GlaxoSmithKline Inc. Major Business
- 2.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product and Services
- 2.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 GlaxoSmithKline Inc. Recent Developments/Updates
- 2.4 Takeda Pharmaceutical Company
- 2.4.1 Takeda Pharmaceutical Company Details
- 2.4.2 Takeda Pharmaceutical Company Major Business
- 2.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product and Services
- 2.4.4 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
3 Competitive Environment: Measles and Rubella Vaccines by Manufacturer
- 3.1 Global Measles and Rubella Vaccines Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Measles and Rubella Vaccines Revenue by Manufacturer (2018-2023)
- 3.3 Global Measles and Rubella Vaccines Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Measles and Rubella Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Measles and Rubella Vaccines Manufacturer Market Share in 2022
- 3.4.2 Top 6 Measles and Rubella Vaccines Manufacturer Market Share in 2022
- 3.5 Measles and Rubella Vaccines Market: Overall Company Footprint Analysis
- 3.5.1 Measles and Rubella Vaccines Market: Region Footprint
- 3.5.2 Measles and Rubella Vaccines Market: Company Product Type Footprint
- 3.5.3 Measles and Rubella Vaccines Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Measles and Rubella Vaccines Market Size by Region
- 4.1.1 Global Measles and Rubella Vaccines Sales Quantity by Region (2018-2029)
- 4.1.2 Global Measles and Rubella Vaccines Consumption Value by Region (2018-2029)
- 4.1.3 Global Measles and Rubella Vaccines Average Price by Region (2018-2029)
- 4.2 North America Measles and Rubella Vaccines Consumption Value (2018-2029)
- 4.3 Europe Measles and Rubella Vaccines Consumption Value (2018-2029)
- 4.4 Asia-Pacific Measles and Rubella Vaccines Consumption Value (2018-2029)
- 4.5 South America Measles and Rubella Vaccines Consumption Value (2018-2029)
- 4.6 Middle East and Africa Measles and Rubella Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
- 5.2 Global Measles and Rubella Vaccines Consumption Value by Type (2018-2029)
- 5.3 Global Measles and Rubella Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
- 6.2 Global Measles and Rubella Vaccines Consumption Value by Application (2018-2029)
- 6.3 Global Measles and Rubella Vaccines Average Price by Application (2018-2029)
7 North America
- 7.1 North America Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
- 7.2 North America Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
- 7.3 North America Measles and Rubella Vaccines Market Size by Country
- 7.3.1 North America Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
- 7.3.2 North America Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
- 8.2 Europe Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
- 8.3 Europe Measles and Rubella Vaccines Market Size by Country
- 8.3.1 Europe Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Measles and Rubella Vaccines Market Size by Region
- 9.3.1 Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Measles and Rubella Vaccines Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
- 10.2 South America Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
- 10.3 South America Measles and Rubella Vaccines Market Size by Country
- 10.3.1 South America Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
- 10.3.2 South America Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Measles and Rubella Vaccines Market Size by Country
- 11.3.1 Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Measles and Rubella Vaccines Market Drivers
- 12.2 Measles and Rubella Vaccines Market Restraints
- 12.3 Measles and Rubella Vaccines Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Measles and Rubella Vaccines and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Measles and Rubella Vaccines
- 13.3 Measles and Rubella Vaccines Production Process
- 13.4 Measles and Rubella Vaccines Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Measles and Rubella Vaccines Typical Distributors
- 14.3 Measles and Rubella Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Measles and Rubella Vaccines. Industry analysis & Market Report on Measles and Rubella Vaccines is a syndicated market report, published as Global Measles and Rubella Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Measles and Rubella Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
